Lymphadenopathy epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 6: Line 6:
The estimated incidence of [[lymphadenopathy]] in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.
The estimated incidence of [[lymphadenopathy]] in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.
* Lymphadenopathy is very common.  
* Lymphadenopathy is very common.  
==Epidemiology and Demographics==
===Incidence===
*The estimated incidence of lymphadenopathy among children in the United States ranges from 35%- 45%.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref>
*The estimated incidence of lymphadenopathy among children in the United States ranges from 35%- 45%.<ref name="pmid24753638">{{cite journal |vauthors=Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A |title=Peripheral lymphadenopathy: approach and diagnostic tools |journal=Iran J Med Sci |volume=39 |issue=2 Suppl |pages=158–70 |year=2014 |pmid=24753638 |pmc=3993046 |doi= |url=}}</ref>


Line 27: Line 29:
[[Category:Hematology]]
[[Category:Hematology]]
[[Category:Physical examination]]
[[Category:Physical examination]]
[[Category:Needs content]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 15:18, 23 January 2019

Lymphadenopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Lymphadenopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT scan

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Lymphadenopathy epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lymphadenopathy epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lymphadenopathy epidemiology and demographics

CDC on Lymphadenopathy epidemiology and demographics

Lymphadenopathy epidemiology and demographics in the news

Blogs on Lymphadenopathy epidemiology and demographics

Directions to Hospitals Treating Lymphadenopathy

Risk calculators and risk factors for Lymphadenopathy epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2] Raviteja Guddeti, M.B.B.S. [3]

Overview

The estimated incidence of lymphadenopathy in children in the United States ranges from 35%- 45%. It is more common in the pediatric population. Race and gender have no predilection in lymphadenopathy incidence.

  • Lymphadenopathy is very common.

Epidemiology and Demographics

Incidence

  • The estimated incidence of lymphadenopathy among children in the United States ranges from 35%- 45%.[1]

Age

  • Patients of all age groups may develop lymphadenopathy.
  • Lymphadenopathy is more commonly observed among children.

Gender

  • Lymphadenopathy affects men and women equally.

Race

  • There is no racial predilection for lymphadenopathy.[1]

References

  1. 1.0 1.1 Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.

Template:WH Template:WS